Camlin Fine Sciences Ltd
Camlin Fine Sciences Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #11 of 68 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Based on Camlin Fine Sciences Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) - Segment revenues Q2 FY27 vs Q2 FY26 (Page 7, 8): - Specialty Ingredients - Straights: Rs 1,108 mn, +26% YoY - S Q2 FY27 EBITDA: Rs 22.3 Mn, down sharply from Rs 356.3 Mn in Q2 FY26 (approx.
From Camlin Fine Sciences Ltd's Q2 FY27 earnings-call transcript · updated 3 Nov 2026.
How did Camlin Fine Sciences' revenue grow in the September 2026 quarter?
- Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9)
- Segment revenues Q2 FY27 vs Q2 FY26 (Page 7, 8):
- Specialty Ingredients - Straights: Rs 1,108 mn, +26% YoY
- Specialty Ingredients - Value Added Blends: Rs 2,970 mn, +26% YoY
- Aroma Ingredients: Rs 472 mn, -41% YoY (due to Methyl Vanillin changeover)
- Growth indicated by revenue increases
- Outlook (Page 6):
- Blends: Growth momentum expected to continue globally
2 more points from Camlin Fine Sciences Ltd's call on revenue
Create a free account to keep reading this call
What happened to Camlin Fine Sciences' margins in Q2 FY27?
See what Camlin Fine Sciences Ltd said on profitability & margins — free account, 30 seconds.
What capex is Camlin Fine Sciences planning?
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Camlin Fine Sciences raising money or cutting debt?
See what Camlin Fine Sciences Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Camlin Fine Sciences' order book?
See what Camlin Fine Sciences Ltd said on order book & pipeline — free account, 30 seconds.
Camlin Fine Sciences Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q2 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹425 Cr, net profit ₹86 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Camlin Fine's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Gujarat Fluoroch (Q2 FY27)
Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv
- Bodal Chemicals (Q2 FY27)
8,840 mn, up 77% YoY (from Rs. Key investor presentation takeaways from Bodal Chemicals Ltd's Q2 FY27 investor presentation — and how it ranks against sector pe
- Solar Industries (Q2 FY27)
3,519 crore, up 69% YoY from Rs. Key investor presentation takeaways from Solar Industries India Ltd's Q2 FY27 investor presentation — and how it ranks against
- Tamil Nadu Petro Products (Q2 FY27)
For the quarter ended 30-Sep-2026, the standalone revenue from operations was ₹93,437 lakh, up from ₹77,792 lakh in Q2 2025, reflecting a year-on-year…
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Camlin Fine Sciences Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Camlin Fine Sciences Ltd Q2 FY27 results?
Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) - Segment revenues Q2 FY27 vs Q2 FY26 (Page 7, 8): - Specialty Ingredients - Straights: Rs 1,108 mn, +26% YoY - S Q2 FY27 EBITDA: Rs 22.3 Mn, down sharply from Rs 356.3 Mn in Q2 FY26 (approx.
What is Camlin Fine Sciences Ltd share price analysis?
Camlin Fine Sciences Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹1,699 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Camlin Fine Sciences Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.